Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of butylphthalide soft capsules in vascular dementia
CTR20190809Phase 3Active
- Sponsor
- CSPC NBP Pharmaceutical
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of butylphthalide in vascular dementia, sponsored by CSPC NBP Pharmaceutical. Started May 2020; status: active.
02
Drugs
butylphthalide
03
Conditions
vascular dementia
Beyond the preview
Go deeper on CTR20190809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190809.